Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pediatric high-grade gliomas.

Alyssa T Reddy1, John C Wellons

  • 1Department of Pediatrics, University of Alabama at Birmingham, The Children's Hospital of Alabama, Birmingham, Alabama 35233, USA.

Cancer Journal (Sudbury, Mass.)
|June 6, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Late cerebrospinal fluid shunt infections: a Hydrocephalus Clinical Research Network study.

Journal of neurosurgery. Pediatrics·2026
Same author

Decompression with or without Duraplasty for Chiari I and Syringomyelia.

The New England journal of medicine·2026
Same author

Outcomes following radiotherapy for atypical teratoid/rhabdoid tumor in combination with surgery and intensive chemotherapy: A report from Children's Oncology Group study ACNS0333.

Neuro-oncology pediatrics·2026
Same author

AEGIS reveals epitope- and clone-resolved convergence of CNS B and T cell autoreactivity in ROHHAD.

bioRxiv : the preprint server for biology·2026
Same author

In-Utero Myelomeningocele Repair: Historical Evolution, Technical Refinements, and Global Impact of the Vanderbilt Experience.

Annals of plastic surgery·2026
Same author

Clinical presentation of hydrocephalus following pre- and postnatal myelomeningocele repair: a Hydrocephalus Clinical Research Network study.

Journal of neurosurgery. Pediatrics·2026
Same journal

Present and Emerging Strategies for Disease Assessment in Hodgkin Lymphoma.

Cancer journal (Sudbury, Mass.)·2026
Same journal

Nodular Lymphocyte-predominant Hodgkin Lymphoma: Incidence, Pathogenesis, Management.

Cancer journal (Sudbury, Mass.)·2026
Same journal

Management of Classic Hodgkin Lymphoma in Special Clinical Situations.

Cancer journal (Sudbury, Mass.)·2026
Same journal

Older Patients With Hodgkin Lymphoma: A Contemporary Review.

Cancer journal (Sudbury, Mass.)·2026
Same journal

Adolescent and Young Adult Patients With Classical Hodgkin Lymphoma: A Review as a Case Study in AYA Cancer Care.

Cancer journal (Sudbury, Mass.)·2026
Same journal

Hodgkin Lymphoma: Management of Patients Who Fail Primary Therapy.

Cancer journal (Sudbury, Mass.)·2026
See all related articles

Pediatric high-grade gliomas are challenging to treat, with limited survival despite aggressive multimodal therapy. Novel combined treatments are essential for improving outcomes in children with these aggressive brain tumors.

Area of Science:

  • Pediatric Oncology
  • Neuro-Oncology
  • Cancer Therapeutics

Background:

  • High-grade gliomas (HGGTs) in children, including glioblastoma multiforme, present significant treatment challenges.
  • Current multimodal therapies yield poor survival rates for affected children.

Purpose of the Study:

  • To review current treatment strategies for pediatric high-grade gliomas.
  • To explore novel therapeutic approaches for improving patient survival.

Main Methods:

  • Review of published data on surgical resection, radiation therapy, and chemotherapy for pediatric HGGTs.
  • Analysis of ongoing and proposed studies investigating novel agents and biologic therapies.

Main Results:

  • Aggressive surgical resection correlates with improved survival compared to biopsy or partial resection.

Related Experiment Videos

  • Radiation therapy is a mainstay adjuvant treatment that prolongs survival but is rarely curative.
  • Chemotherapy shows response but lacks compelling evidence for survival prolongation.

    • Conclusions:

    • Improved survival for pediatric high-grade gliomas necessitates combined therapeutic strategies.
    • Investigational therapies include radiosensitizers, anti-angiogenesis factors, growth factor receptor inhibitors, free radical inducers, and gene therapy.